Explore press releases, blog posts, and more.

Resources & Media

Resources

Categories: Press Releases
Lund University features Jan Nilsson’s experiment results on Orticumab, Highlighting the Promising Results of Reducing the Risk of Dying from a Heart Attack
Read the full article
Categories: Press Releases
American College of Cardiology Presentation Highlights Orticumab’s Promising Results Showing Potential to Reduce Coronary Inflammation
Read the full article
Categories: Press Releases
Entrepreneur and Cardiologist Michael H. Davidson Appointed to Board of Directors
Read the full article
Categories: Press Releases
Abcentra Announces First Patients Dosed with Orticumab in Clinical Trial
Read the full article
Categories: Press Releases
Timothy Wright Joins Board of Directors
Read the full article
Categories: Press Releases
CardioVax Announces Name Change to Abcentra
Read the full article
Categories: Blogs
Glossary of Important Coronary Artery Disease Terminology
Read the full article

Events

Seville, Spain

September 23, 2024

Imperial Vulnerable Patient and Plaque Meeting (VPM)
Join Us
London, UK

August 30, 2024

European Society of Cardiology (ESC)
Join Us
San Diego, CA

June 3, 2024

BIO USA
Join Us
Stockholm, Sweden

November 4, 2024

BIO-Europe (Fall)
Join Us
Chicago, IL

November 16, 2024

American Heart Association (AHA)
Join Us

about Abcentra

At Abcentra, we believe that it is possible to live in a world without heart attacks. Our work is focused on bringing new and better treatment options to patients with coronary artery disease.

Learn More

Resources & Media

Resources

Events

about Abcentra

Keep up to date on Abcentra’s work